CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on July 30, 2008
Clin J Am Soc Nephrol 3: 1569-1572, 2008
© 2008 American Society of Nephrology
doi: 10.2215/CJN.02370508

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.02370508v1
3/5/1569    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Melamed, M. L.
Right arrow Articles by Hostetter, T. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melamed, M. L.
Right arrow Articles by Hostetter, T. H.

Controversies in Nephrology

eGFR: Is It Ready for Early Identification of CKD?

Michal L. Melamed, Carolyn Bauer, and Thomas H. Hostetter

Albert Einstein College of Medicine, Bronx, New York

Correspondence: Dr. Thomas H. Hostetter, Renal Division, Abraham Levitt Professor of Medicine, Albert Einstein College of Medicine, Room 615, Ullmann Building, 1300 Morris Park Avenue, Bronx, NY 10461. Phone: 718-430-3158; Fax: 718-430-8963; E-mail: thostett{at}aecom.yu.edu

Reporting estimated glomerular filtration rate (eGFR) with serum creatinine simply provides the information for which the serum creatinine was ordered in the first place. Mass or universal screening is not the purpose of eGFR reporting. Furthermore, such mass screening does not seem justified. Rather, testing of high-risk groups with eGFR and urinary albumin is useful. Population estimates of the prevalence of chronic kidney disease in the United States that use the Kidney Disease Outcomes Quality Initiative staging system lead to disturbingly high estimates. Many of these people are elderly with marginally depressed GFRs and for whom there are no known therapeutic implications. However, an even more disturbing fraction of people with serious and progressive renal disease are not diagnosed, counseled, or treated. Reporting of eGFR is only one tool in attempting to rectify this latter problem. Nephrologists need to educate patients and their primary care colleagues in the use of this tool.




This article has been cited by other articles:


Home page
CJASNHome page
R. Botev and J.-P. Mallie
Reporting the eGFR and Its Implication for CKD Diagnosis
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1606 - 1607.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Nephrology.